Loss of function mutations in ZFHX3 are frequently detected in human cancers i.e. high-grade human prostate cancers37, endometrial cancers38, urothelial bladder carcinoma39, lung and brain tumors40. This evidence concerns the gene ZFHX3 and cancer.